2022
DOI: 10.15252/emmm.202216789
|View full text |Cite
|
Sign up to set email alerts
|

Whole‐brain microscopy reveals distinct temporal and spatial efficacy of anti‐Aβ therapies

Abstract: Many efforts targeting amyloid-β (Aβ) plaques for the treatment of Alzheimer's Disease thus far have resulted in failures during clinical trials. Regional and temporal heterogeneity of efficacy and dependence on plaque maturity may have contributed to these disappointing outcomes. In this study, we mapped the regional and temporal specificity of various anti-Aβ treatments through high-resolution light-sheet imaging of electrophoretically cleared brains. We assessed the effect on amyloid plaque formation and gr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 53 publications
0
9
0
Order By: Relevance
“…The regional and temporal heterogeneity of amyloid-β (Aβ) plaque formation in mouse brains subject to various treatments is a promising direction in Alzheimer’s disease research 13 . An APP/PS1 mouse brain cleared with iDISCO 47 is shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The regional and temporal heterogeneity of amyloid-β (Aβ) plaque formation in mouse brains subject to various treatments is a promising direction in Alzheimer’s disease research 13 . An APP/PS1 mouse brain cleared with iDISCO 47 is shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…However, this is not the full explanation. A previous study treating APPPS1 mice with a BACE-1 inhibitor that decreased total Aβ production and hence the number and size of Aβ-amyloid plaque in young mice, but the qFTAA/hFTAA ratio was altered by increasing in cortical regions and decreasing in thalamus, hypothalamus, and hindbrain regions (55). No difference was seen in treated versus non-treated 14 Mo old APPPS1 mice.…”
Section: Resultsmentioning
confidence: 99%
“…A previous study treating APPPS1 mice with a BACE-1 inhibitor decreased total Aβ production and hence the number and size of Aβ-amyloid plaque in young mice, but the qFTAA/hFTAA ratio was altered by increasing in cortical regions and decreasing in the thalamus, hypothalamus, and hindbrain regions. 57 No difference was seen in treated versus nontreated 14-month-old APPPS1 mice. These results indicate that the issue is more complex than merely Aβ-concentration.…”
Section: How Do Aβ Plaque Structures In Mouse Models Relate To Human ...mentioning
confidence: 95%